Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
Sustained efficacy and safety through 2 years in patients with rheumatoid arthritis (RA) in the long-term extension of the ATTAIN trial. 70th Annual Scientific Meeting of the American-College-of-Rheumatology/41st Annual Scientific Meeting of the Association-of-Rheumatology-Health-Professionals Genovese, M. C., Schiff, M., Luggen, M., Becker, J., Aranda, R., McCann, T., Schmidely, N., Le Bars, M., Dougados, M. WILEY-BLACKWELL. 2006: S244–S244
View details for Web of Science ID 000240877201068